TAZIP
4G/0,5G INF PLV SOL 10
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 27.01.2021 | |||
| Interruption of marketing | 01.07.2020 |
0113424, 0141263 |
Manufacturing reasons | 2.1.2021 |
| Interruption of marketing | 09.04.2020 |
0113424, 0141263 |
Manufacturing reasons | 30.06.2020 |
| Resumption of marketing | 06.01.2020 | |||
| Interruption of marketing | 29.04.2019 |
0141263 |
Manufacturing reasons | leden 2020 |
| Interruption of marketing | 29.04.2019 |
0141263 |
Manufacturing reasons | 10.09.2019 |
| Interruption of marketing | 29.04.2019 |
0141263 |
Manufacturing reasons | 29.06.2019 |
| Resumption of marketing | 04.02.2019 | |||
| Interruption of marketing | 31.10.2018 | lék je nenahraditelný | Manufacturing reasons | 20.02.2019 |
| Resumption of marketing | 20.09.2018 | |||
| Interruption of marketing | 12.04.2018 | Lék není nahraditelný | ||
| Placing on the market | 11.03.2010 | |||
| Placing on the market | 22.03.2010 |
All reports are available in the Overview.
cz